Jacob Waugh
2013
In 2013, Jacob Waugh earned a total compensation of $1.3M as Chief Scientific Officer at Revance Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $38,639 |
|---|---|
| Option Awards | $912,717 |
| Salary | $343,460 |
| Total | $1,294,816 |
Waugh received $912.7K in option awards, accounting for 70% of the total pay in 2013.
Waugh also received $38.6K in non-equity incentive plan and $343.5K in salary.
Rankings
In 2013, Jacob Waugh's compensation ranked 5,525th out of 12,286 executives tracked by ExecPay. In other words, Waugh earned more than 55.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,525 out of 12,286 | 55th |
Division Manufacturing | 1,927 out of 4,612 | 58th |
Major group Chemicals And Allied Products | 557 out of 1,462 | 62nd |
Industry group Drugs | 398 out of 1,156 | 66th |
Industry Pharmaceutical Preparations | 318 out of 890 | 64th |
Source: SEC filing on March 26, 2015.
Waugh's colleagues
We found one more compensation record of an executive who worked with Jacob Waugh at Revance Therapeutics in 2013.
2013
L Browne
Revance Therapeutics